TMAO: a potential mediator of clopidogrel resistance
Abstract Trimethylamine-N-oxide (TMAO) can activate platelets and increase thrombosis risk in clinical and experimental models. Meanwhile, the patients with coronary artery disease have higher serum TMAO level. However, it remains unknown whether Clopidogrel Resistance (CR) could be attributed to TM...
Enregistré dans:
Auteurs principaux: | Ruisong Ma, Wenwen Fu, Jing Zhang, Xiaorong Hu, Jun Yang, Hong Jiang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b6f0fcb212214607899980f1b51ec8cd |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Untargeted metabolomics and transcriptomics identified glutathione metabolism disturbance and PCS and TMAO as potential biomarkers for ER stress in lung
par: Zijing Wang, et autres
Publié: (2021) -
Resveratrol Attenuates Trimethylamine-<italic toggle="yes">N</italic>-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota
par: Ming-liang Chen, et autres
Publié: (2016) -
Contribution of multidrug and toxin extrusion protein 1 (MATE1) to renal secretion of trimethylamine-N-oxide (TMAO)
par: A. Gessner, et autres
Publié: (2018) -
Gut microbiota derived trimethylamine N-oxide (TMAO) detection through molecularly imprinted polymer based sensor
par: G. B. V. S. Lakshmi, et autres
Publié: (2021) -
Risk of postpolypectomy bleeding in patients taking direct oral anticoagulants or clopidogrel
par: Gwang-Un Kim, et autres
Publié: (2021)